跳至主要内容
临床试验/CTRI/2022/09/045680
CTRI/2022/09/045680尚未招募未知

Serum Co-Peptin as a Biomarker of Polycystic ovarian syndrome and Its Correlation with Metabolic Syndrome components -

FATHER MULLER MEDICAL COLLEGE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients fulfilling all the features of Rotterdamââ?¬•s criteria diagnosed as PCOS.

排除标准

  • Based on history and clinical records
  • ââ?¬Â¢ H/O smoking
  • ââ?¬Â¢ Diabetes mellitus
  • ââ?¬Â¢ Hyperprolactinemia
  • ââ?¬Â¢ Congenital adrenal hyperplasia
  • ââ?¬Â¢ Androgen-secreting tumors
  • ââ?¬Â¢ Thyroid disorders
  • ââ?¬Â¢ Cushing syndrome (1 mg dexamethasone suppression test)
  • ââ?¬Â¢ Infectious diseases
  • ââ?¬Â¢ Hypertension
  • ââ?¬Â¢ Hepatic or renal dysfunction.
  • ââ?¬Â¢Usage within 3 months before enrollment confounding medications, including oral contraceptive agents, antilipidemic drugs, hypertensive medications, and insulin-sensitizing drugs

研究者

发起方
FATHER MULLER MEDICAL COLLEGE

相似试验